All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
MRNA real return snapshot: after CPI-U inflation, MRNA returned +445.64% over the past year and +352.98% YTD, with dividends reinvested. Since Dec. 7, 2018, MRNA is up +458.19% in real purchasing-power return, or +24.94%/yr, and is currently −76.76% below its real total-return high on Aug. 9, 2021.
Data ending Fri Aug. 28, 2026
| Fri 2018-12-07💬 to Fri 2026-08-28 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+458.19%
+24.94%/yr |
−0.16%/yr
R2=0.000 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07💬 to Fri 2026-08-28 |
Start
Value |
End
Value |
|---|---|---|
| MRNA × |
$10,000.00
2018-12-07 |
$55,819.44
2026-08-28 |
| YTD | YoY | |
|---|---|---|
| MRNA × | +352.98% | +445.64% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| MRNA × |
−76.76%
on 2026-08-28 from 2021-08-09 peak |
−96.11%
on 2025-11-20 from 2021-08-09 peak |
| Period ending Fri 2026-08-28 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| MRNA × | +445.64% |
+65.60% +28.68%/yr |
+11.14% +3.58%/yr |
−70.50% −21.66%/yr |
— |
| Year | MRNA |
|---|---|
| 2026 (YTD) | +352.98% |
| 2025 | −30.92% |
| 2024 | −59.36% |
| 2023 | −46.43% |
| 2022 | −33.57% |
| 2021 | +127.13% |
| 2020 | +426.92% |
| 2019 | +25.23% |
| 2018 | −17.70% |